Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Theurich

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
Critical Reviews in Oncology/Hematology|January 22, 2015
Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults - a systematic review and meta-analysisUdo Holtick, Melanie Albrecht, Jens M Chemnitz, et al.
European Journal of Haematology|October 23, 2015
Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibodyGeothy Chakupurakal, María Alejandra García-Márquez, Alexander Shimabukuro-Vornhagen, et al.
Nutrients|October 27, 2022
Risk Stratification Based on a Pattern of Immunometabolic Host Factors Is Superior to Body Mass Index-Based Prediction of COVID-19-Associated Respiratory FailureDavid M Cordas Dos Santos, Lian Liu, Melvin Gerisch, et al.
European Journal of Haematology|April 15, 2024
Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trialTim Richardson, Christof Scheid, Marco Herling, et al.
Annals of Hematology|May 18, 2011
Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemiaJens Marcus Chemnitz, Marie von Lilienfeld-Toal, Udo Holtick, et al.
Leukemia & Lymphoma|June 29, 2013
18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphomaDeniz Kahraman, Sebastian Theurich, Achim Rothe, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 22, 2026
An oBservational retrospective Analysis of treatment patternS and Effectiveness of standard of CAre for Multiple Myeloma Patients Exposed to Lenalidomide and a Proteasome Inhibitor: BasecaMMp StudyKlaus Martin Kortüm, James Farrell, Olivia Ashman, et al.
Cancer & Metabolism|May 5, 2021
High-resolution spatiotemporal pH<sub>e</sub> and pO<sub>2</sub> imaging in head and neck and oesophageal carcinoma cellsAlexandra Blancke Soares, Robert Meier, Gregor Liebsch, et al.
Nature Communications|May 4, 2017
Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistanceElaine Xu, Mafalda M A Pereira, Ismene Karakasilioti, et al.
Transplantation|August 7, 2013
CD30-targeted therapy with brentuximab vedotin and DLI in a patient with T-cell posttransplantation lymphoma: induction of clinical remission and cellular immunitySebastian Theurich, Kerstin Wennhold, Inga Wedemeyer, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Critical Reviews in Oncology/Hematology|January 22, 2015
Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults - a systematic review and meta-analysisUdo Holtick, Melanie Albrecht, Jens M Chemnitz, et al.
European Journal of Haematology|October 23, 2015
Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibodyGeothy Chakupurakal, María Alejandra García-Márquez, Alexander Shimabukuro-Vornhagen, et al.
Nutrients|October 27, 2022
Risk Stratification Based on a Pattern of Immunometabolic Host Factors Is Superior to Body Mass Index-Based Prediction of COVID-19-Associated Respiratory FailureDavid M Cordas Dos Santos, Lian Liu, Melvin Gerisch, et al.
European Journal of Haematology|April 15, 2024
Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trialTim Richardson, Christof Scheid, Marco Herling, et al.
Annals of Hematology|May 18, 2011
Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemiaJens Marcus Chemnitz, Marie von Lilienfeld-Toal, Udo Holtick, et al.
Leukemia & Lymphoma|June 29, 2013
18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphomaDeniz Kahraman, Sebastian Theurich, Achim Rothe, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 22, 2026
An oBservational retrospective Analysis of treatment patternS and Effectiveness of standard of CAre for Multiple Myeloma Patients Exposed to Lenalidomide and a Proteasome Inhibitor: BasecaMMp StudyKlaus Martin Kortüm, James Farrell, Olivia Ashman, et al.
Cancer & Metabolism|May 5, 2021
High-resolution spatiotemporal pH<sub>e</sub> and pO<sub>2</sub> imaging in head and neck and oesophageal carcinoma cellsAlexandra Blancke Soares, Robert Meier, Gregor Liebsch, et al.
Nature Communications|May 4, 2017
Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistanceElaine Xu, Mafalda M A Pereira, Ismene Karakasilioti, et al.
Transplantation|August 7, 2013
CD30-targeted therapy with brentuximab vedotin and DLI in a patient with T-cell posttransplantation lymphoma: induction of clinical remission and cellular immunitySebastian Theurich, Kerstin Wennhold, Inga Wedemeyer, et al.
Pageof 15